Erasca (ERAS) Total Liabilities (2020 - 2026)

Erasca (ERAS) reported Total Liabilities of $67.7 million for Q1 2026, down 5.63% on a YoY basis from $71.7 million in Q1 2025, and down 4.62% quarter-over-quarter from $71.0 million in Q4 2025.

Erasca (ERAS) Total Liabilities (2020 - 2026) Analysis & Trends

Erasca has reported Total Liabilities for 7 years, with the latest figure at $67.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Liabilities fell 5.63% year-over-year to $67.7 million; the trailing twelve-month figure through Mar 2026 stood at $67.7 million (down 5.63% YoY), and the FY2025 full-year result was $71.0 million, down 10.18% from the prior year.
  • Total Liabilities for Q1 2026 stood at $67.7 million, down from $71.0 million in the prior quarter.
  • The five-year high for Total Liabilities was $103.1 million in Q4 2022, with the low at $49.8 million in Q2 2022.
  • Historically, Total Liabilities has averaged $74.9 million across 5 years, with a median of $78.0 million in 2023.
  • The largest YoY upside for Total Liabilities was 154.09% in 2022 against a maximum downside of 60.69% in 2022.
  • Erasca's Total Liabilities stood at $103.1 million in 2022, then retreated by 23.72% to $78.6 million in 2023, then increased by 0.53% to $79.0 million in 2024, then slipped by 10.18% to $71.0 million in 2025, then fell by 4.62% to $67.7 million in 2026.
  • The last three Total Liabilities figures came in at $67.7 million (Q1 2026), $71.0 million (Q4 2025), and $72.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1.74 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 15.48 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 16.35 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 731.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 10.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 19.51 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 943,068.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 7.12 Bn
9 Abivax 91.96 Bn 91.96 Bn - 137.56 Mn
10 Erasca 4.16 Bn 3.92 Bn - 67.71 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 67.71 Mn
Dec 31, 2025 70.98 Mn
Sep 30, 2025 72.52 Mn
Jun 30, 2025 73.13 Mn
Mar 31, 2025 71.74 Mn
Dec 31, 2024 79.03 Mn
Sep 30, 2024 78.85 Mn
Jun 30, 2024 74.66 Mn
Mar 31, 2024 81.61 Mn
Dec 31, 2023 78.61 Mn
Sep 30, 2023 80.43 Mn
Jun 30, 2023 77.96 Mn
Mar 31, 2023 81.09 Mn
Dec 31, 2022 103.06 Mn
Sep 30, 2022 81.11 Mn
Jun 30, 2022 49.76 Mn
Mar 31, 2022 50.81 Mn
Dec 31, 2021 44.89 Mn
Sep 30, 2021 38.96 Mn
Jun 30, 2021 19.58 Mn